Jaguar Health, Inc.
-9.2 %
135.18 %
Yet to be announced
Company Overview
Jaguar Health, Inc. is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Their lead product is Mytesi® (crofelemer), which is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Revenue Sources
PassBased on the company's SEC filings and financial statements, Jaguar Health's primary revenue comes from their pharmaceutical products, particularly Mytesi®, which is a plant-based medicine. Their research, development, and commercialization activities are focused on legitimate medical treatments and do not involve any haram elements. The company's business model and revenue sources are halal-compliant.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Dec. 31, 2024 | $3.51m | $11.56m | - | $-110,000.0 | 0.00% | 0.95% |
| Sept. 30, 2024 | $3.11m | $10.21m | - | $-160,000.0 | 0.00% | 1.59% |
| June 30, 2024 | $2.72m | $9.81m | - | $-110,000.0 | 0.00% | 1.10% |
| March 31, 2024 | $2.35m | $9.93m | - | $-630,000.0 | 0.00% | 6.38% |
The company has had consistent interest expenses over the past four quarters, but the levels are not material relative to their total expenses. Interest expense ratios have remained below significant thresholds when compared to total expenses for each quarter. While the company does have some debt financing, it is not a core part of their business model.
Operational Ethics
PassBased on available information from SEC filings and company disclosures, Jaguar Health does not maintain any significant operations or partnerships with entities involved in human rights violations. The company's primary operations are in the United States, with their supply chain focused on sustainable plant sourcing from South America.
Comments